Durability of fenestrated endovascular aortic repair for juxta-renal abdominal aortic aneurysm repair

Standard

Durability of fenestrated endovascular aortic repair for juxta-renal abdominal aortic aneurysm repair. / Spanos, Konstantinos; Antoniou, George Α; Giannoukas, Athanasios D; Rohlffs, Fiona; Tsilimparis, Nikolaos; Debus, Sebastian E; Kölbel, Tilo.

In: J CARDIOVASC SURG, Vol. 59, No. 2, 04.2018, p. 213-224.

Research output: SCORING: Contribution to journalSCORING: Review articleResearch

Harvard

APA

Vancouver

Bibtex

@article{2f3b42c66c1d402d98a3c331caf4a9ce,
title = "Durability of fenestrated endovascular aortic repair for juxta-renal abdominal aortic aneurysm repair",
abstract = "BACKGROUND: The aim of this study was to evaluate the long term durability of fenestrated endovascular aortic aneurysm repair (F-EVAR) of juxta-renal aortic aneurysms (JAAAs) in terms of mortality, target visceral vessel (TVV) patency and Reintervention rates.EVIDENCE ACQUISITION: A systematic review and meta-analysis was performed. MEDLINE, CENTRAL, and Cochrane databases were searched with PRISMA methodology for studies reporting on F-EVAR of JAAA presenting follow-up >36 months. Articles with <15 patients, follow-up <36 months, comparison of F-EVAR with other treatment modalities were excluded.EVIDENCE SYNTHESIS: Seven non-randomized retrospective studies of prospectively collected data were analysed including 772 patients (mean age and diameter ranging from 71.5 to 74 years and from 60 to 65mm, respectively) underwent F-EVAR for JAAA during 2001-2015. The pooled mortality rates during 12, 24, 36, 48 and 60 months were 0.080 (0.060-0.106), 0.129 (0.097-0.169), 0.211 (0.158-0.277), 0.279 (0.193-0.386) and 0.405 (0.303-0.517), respectively. The pooled Reintervention rates during 12, 24, 36 and 48 months were 0.097 (0.066-0.140), 0.131 (0.082-0.203), 0.281 (0.182-0.406) and 0.244 (0.103-0.477), respectively. The pooled loss of TVV patency rates during 12, 24, 36, 48 and 60 months were 0.046 (0.035-0.060), 0.081 (0.058-0.110), 0.088 (0.060-0.127), 0.123 (0.067-0.214) and 0.132 (0.081-0.207).CONCLUSIONS: F-EVAR for the treatment of patients with JAAA is a durable procedure with good long term outcomes in terms of mortality and visceral vessels patency. During long term period the need for a Reintervention continues to exists, thus follow-up of those cases may be important for preserving the good results.",
keywords = "Aged, Aged, 80 and over, Aortic Aneurysm, Abdominal/diagnostic imaging, Blood Vessel Prosthesis, Blood Vessel Prosthesis Implantation/adverse effects, Endovascular Procedures/adverse effects, Female, Humans, Male, Middle Aged, Postoperative Complications/etiology, Prosthesis Design, Risk Factors, Stents, Time Factors, Treatment Outcome, Vascular Patency",
author = "Konstantinos Spanos and Antoniou, {George Α} and Giannoukas, {Athanasios D} and Fiona Rohlffs and Nikolaos Tsilimparis and Debus, {Sebastian E} and Tilo K{\"o}lbel",
year = "2018",
month = apr,
doi = "10.23736/S0021-9509.18.10341-7",
language = "English",
volume = "59",
pages = "213--224",
journal = "J CARDIOVASC SURG",
issn = "0021-9509",
publisher = "Edizioni Minerva Medica S.p.A.",
number = "2",

}

RIS

TY - JOUR

T1 - Durability of fenestrated endovascular aortic repair for juxta-renal abdominal aortic aneurysm repair

AU - Spanos, Konstantinos

AU - Antoniou, George Α

AU - Giannoukas, Athanasios D

AU - Rohlffs, Fiona

AU - Tsilimparis, Nikolaos

AU - Debus, Sebastian E

AU - Kölbel, Tilo

PY - 2018/4

Y1 - 2018/4

N2 - BACKGROUND: The aim of this study was to evaluate the long term durability of fenestrated endovascular aortic aneurysm repair (F-EVAR) of juxta-renal aortic aneurysms (JAAAs) in terms of mortality, target visceral vessel (TVV) patency and Reintervention rates.EVIDENCE ACQUISITION: A systematic review and meta-analysis was performed. MEDLINE, CENTRAL, and Cochrane databases were searched with PRISMA methodology for studies reporting on F-EVAR of JAAA presenting follow-up >36 months. Articles with <15 patients, follow-up <36 months, comparison of F-EVAR with other treatment modalities were excluded.EVIDENCE SYNTHESIS: Seven non-randomized retrospective studies of prospectively collected data were analysed including 772 patients (mean age and diameter ranging from 71.5 to 74 years and from 60 to 65mm, respectively) underwent F-EVAR for JAAA during 2001-2015. The pooled mortality rates during 12, 24, 36, 48 and 60 months were 0.080 (0.060-0.106), 0.129 (0.097-0.169), 0.211 (0.158-0.277), 0.279 (0.193-0.386) and 0.405 (0.303-0.517), respectively. The pooled Reintervention rates during 12, 24, 36 and 48 months were 0.097 (0.066-0.140), 0.131 (0.082-0.203), 0.281 (0.182-0.406) and 0.244 (0.103-0.477), respectively. The pooled loss of TVV patency rates during 12, 24, 36, 48 and 60 months were 0.046 (0.035-0.060), 0.081 (0.058-0.110), 0.088 (0.060-0.127), 0.123 (0.067-0.214) and 0.132 (0.081-0.207).CONCLUSIONS: F-EVAR for the treatment of patients with JAAA is a durable procedure with good long term outcomes in terms of mortality and visceral vessels patency. During long term period the need for a Reintervention continues to exists, thus follow-up of those cases may be important for preserving the good results.

AB - BACKGROUND: The aim of this study was to evaluate the long term durability of fenestrated endovascular aortic aneurysm repair (F-EVAR) of juxta-renal aortic aneurysms (JAAAs) in terms of mortality, target visceral vessel (TVV) patency and Reintervention rates.EVIDENCE ACQUISITION: A systematic review and meta-analysis was performed. MEDLINE, CENTRAL, and Cochrane databases were searched with PRISMA methodology for studies reporting on F-EVAR of JAAA presenting follow-up >36 months. Articles with <15 patients, follow-up <36 months, comparison of F-EVAR with other treatment modalities were excluded.EVIDENCE SYNTHESIS: Seven non-randomized retrospective studies of prospectively collected data were analysed including 772 patients (mean age and diameter ranging from 71.5 to 74 years and from 60 to 65mm, respectively) underwent F-EVAR for JAAA during 2001-2015. The pooled mortality rates during 12, 24, 36, 48 and 60 months were 0.080 (0.060-0.106), 0.129 (0.097-0.169), 0.211 (0.158-0.277), 0.279 (0.193-0.386) and 0.405 (0.303-0.517), respectively. The pooled Reintervention rates during 12, 24, 36 and 48 months were 0.097 (0.066-0.140), 0.131 (0.082-0.203), 0.281 (0.182-0.406) and 0.244 (0.103-0.477), respectively. The pooled loss of TVV patency rates during 12, 24, 36, 48 and 60 months were 0.046 (0.035-0.060), 0.081 (0.058-0.110), 0.088 (0.060-0.127), 0.123 (0.067-0.214) and 0.132 (0.081-0.207).CONCLUSIONS: F-EVAR for the treatment of patients with JAAA is a durable procedure with good long term outcomes in terms of mortality and visceral vessels patency. During long term period the need for a Reintervention continues to exists, thus follow-up of those cases may be important for preserving the good results.

KW - Aged

KW - Aged, 80 and over

KW - Aortic Aneurysm, Abdominal/diagnostic imaging

KW - Blood Vessel Prosthesis

KW - Blood Vessel Prosthesis Implantation/adverse effects

KW - Endovascular Procedures/adverse effects

KW - Female

KW - Humans

KW - Male

KW - Middle Aged

KW - Postoperative Complications/etiology

KW - Prosthesis Design

KW - Risk Factors

KW - Stents

KW - Time Factors

KW - Treatment Outcome

KW - Vascular Patency

U2 - 10.23736/S0021-9509.18.10341-7

DO - 10.23736/S0021-9509.18.10341-7

M3 - SCORING: Review article

C2 - 29327565

VL - 59

SP - 213

EP - 224

JO - J CARDIOVASC SURG

JF - J CARDIOVASC SURG

SN - 0021-9509

IS - 2

ER -